Spain· ES:60228
ANSATIPIN 150 MG CÁPSULAS DURAS
A medicinal product containing rifabutina, registered in Spain by Binesa 2002 S.L..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- rifabutina
- Manufacturer
- Binesa 2002 S.L.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo69421630EUR 98.29
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifabutina in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRifabutinMylan Pharmaceuticals Inc.
- FinlandAnsatipinParanova Oy
- NorwayAnsatipinSERB
- United KingdomMycobutin 150mg capsulesPfizer Ltd
- CzechiaMYCOBUTINPfizer, spol. s r.o., Praha
- FranceANSATIPINE 150 mg, géluleSERB
- BelgiumMycobutin 150 mgPfizer
- IrelandMycobutin 150mg Hard CapsulesPfizer Healthcare Ireland Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Mycobutin
- Belgium · Mycobutin
- Czechia · Mycobutin
- Germany · Mycobutin
- Finland · Ansatipin
- France · Ansatipine
- United Kingdom (Northern Ireland) · Mycobutin, Rifabutin Pfizer
- Ireland · Mycobutin
- Italy · Mycobutin
- Luxembourg · Mycobutin
- Netherlands · Mycobutin
- Portugal · Mycobutin
- Sweden · Ansatipin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/94b983db-13a7-403a-8949-becc9e5cec1a GET /v1/drugs/94b983db-13a7-403a-8949-becc9e5cec1a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
"estado": "{\"aut\":786236400000}",
"nregistro": "60228",
"substance": "rifabutina"
}See everything about rifabutina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.